Quarterly Consolidated Statement Of Cash Flows

KOBAYASHI PHARMACEUTICAL CO.,LTD. - Filing #7548751

Concept 2023-01-01 to
2023-06-30
As at
2023-06-30
As at
2022-12-31
2022-01-01 to
2022-06-30
As at
2022-06-30
As at
2021-12-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
11,372,000,000 JPY
22,717,000,000 JPY
Interest and dividends received
342,000,000 JPY
291,000,000 JPY
Interest paid
-13,000,000 JPY
-11,000,000 JPY
Income taxes paid
-4,455,000,000 JPY
-4,178,000,000 JPY
Net cash provided by (used in) operating activities
7,246,000,000 JPY
18,819,000,000 JPY
Cash flows from investing activities
Purchase of securities
-2,000,000,000 JPY
JPY
Purchase of property, plant and equipment
-7,624,000,000 JPY
-4,912,000,000 JPY
Proceeds from sale of property, plant and equipment
2,000,000 JPY
2,000,000 JPY
Purchase of investment securities
-205,000,000 JPY
-6,000,000 JPY
Other, net
-111,000,000 JPY
-127,000,000 JPY
Net cash provided by (used in) investing activities
-8,083,000,000 JPY
-781,000,000 JPY
Cash flows from financing activities
Purchase of treasury shares
JPY
-4,056,000,000 JPY
Dividends paid
-3,950,000,000 JPY
-3,574,000,000 JPY
Other, net
-110,000,000 JPY
-91,000,000 JPY
Net cash provided by (used in) financing activities
-4,061,000,000 JPY
-7,724,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
1,003,000,000 JPY
1,305,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-3,894,000,000 JPY
11,619,000,000 JPY
Cash and cash equivalents
75,586,000,000 JPY
79,480,000,000 JPY
93,584,000,000 JPY
81,987,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.